RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $815M (100.0% shares, 0.0% debt)

Holdings (24)

WVE WAVE LIFE SCIENCES LTD 23.9%
Value $195M Shares 7,088,651 Share Price $27.50 Est. Cost/Share $15.68 Unrealized @ Report Date +78.1%
ASND ASCENDIS PHARMA A S 18.6%
Value $151M Shares 5,409,990 Share Price $28.00 Est. Cost/Share $17.65 Unrealized @ Report Date —
— AVEXIS INC 15.2%
Value $124M Shares 1,625,211 Share Price $76.03 Est. Cost/Share $31.86 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS INC 7.0%
Value $57.4M Shares 13,633,220 Share Price $4.21 Est. Cost/Share $6.18 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 4.4%
Value $36.19M Shares 2,184,047 Share Price $16.57 Est. Cost/Share $13.67 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 3.6%
Value $29.31M Shares 3,489,795 Share Price $8.40 * Est. Cost/Share $9.20 Unrealized @ Report Date -24.4%
— RA PHARMACEUTICALS INC 3.5%
Value $28.78M Shares 1,351,808 Share Price $21.29 Est. Cost/Share $15.19 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 3.4%
Value $27.57M Shares 2,348,422 Share Price $11.74 Est. Cost/Share $12.19 Unrealized @ Report Date —
— ZOGENIX INC 3.3%
Value $26.6M Shares 2,451,237 Share Price $10.85 Est. Cost/Share $13.32 Unrealized @ Report Date —
ESPR ESPERION THERAPEUTICS INC 3.1%
Value $24.88M Shares 704,701 Share Price $35.31 * Est. Cost/Share $22.90 Unrealized @ Report Date 0.0%
— LOXO ONCOLOGY INC 1.5%
Value $12.58M Shares 298,935 Share Price $42.08 Est. Cost/Share $42.08 Unrealized @ Report Date —
ARDX ARDELYX INC 1.3%
Value $10.48M Shares 828,283 Share Price $12.65 * Est. Cost/Share $10.51 Unrealized @ Report Date +25.2%
— ACORDA THERAPEUTICS INC 1.3%
Value $10.29M Shares 489,828 Share Price $21.00 Est. Cost/Share $21.00 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.1%
Value $9.073M Shares 532,426 Share Price $17.04 Est. Cost/Share $17.81 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 1.1%
Value $9.01M Shares 1,820,138 Share Price $4.95 Est. Cost/Share $9.26 Unrealized @ Report Date —
— IGNYTA INC 1.1%
Value $8.818M Shares 1,025,291 Share Price $8.60 Est. Cost/Share $8.60 Unrealized @ Report Date —
ONC BEIGENE LTD 1.1%
Value $8.786M Shares 240,000 Share Price $36.61 Est. Cost/Share $29.62 Unrealized @ Report Date —
— CALITHERA BIOSCIENCES INC 1.0%
Value $8.374M Shares 725,000 Share Price $11.55 Est. Cost/Share $11.55 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 1.0%
Value $8.257M Shares 2,428,571 Share Price $3.40 Est. Cost/Share $28.25 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 1.0%
Value $8.155M Shares 700,000 Share Price $11.65 * Est. Cost/Share $10.06 Unrealized @ Report Date -28.6%
PTGX PROTAGONIST THERAPEUTICS INC 1.0%
Value $8.15M Shares 636,248 Share Price $12.81 * Est. Cost/Share $13.67 Unrealized @ Report Date +17.9%
KALV KALVISTA PHARMACEUTICALS INC 0.6%
Value $4.616M Shares 591,070 Share Price $7.81 * Est. Cost/Share $7.37 Unrealized @ Report Date +1.9%
— EIGER BIOPHARMACEUTICALS INC 0.5%
Value $4.056M Shares 354,200 Share Price $11.45 Est. Cost/Share $16.17 Unrealized @ Report Date —
— MEDICINES CO 0.5%
Value $3.907M Shares 79,899 Share Price $48.90 Est. Cost/Share $33.94 Unrealized @ Report Date —